Candriam S.C.A. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,621,316
-56.4%
51,275
-43.8%
0.01%
-59.3%
Q2 2023$3,722,195
+18.9%
91,2750.0%0.03%
+22.7%
Q1 2023$3,131,133
-1.7%
91,2750.0%0.02%
+4.8%
Q4 2022$3,184,436
-59.7%
91,275
-35.4%
0.02%
-62.5%
Q3 2022$7,906,000
+8.1%
141,2750.0%0.06%
-6.7%
Q2 2022$7,312,000
-0.5%
141,275
+39.7%
0.06%
+20.0%
Q1 2022$7,349,000
-38.5%
101,1270.0%0.05%
-34.2%
Q4 2021$11,957,000
-11.9%
101,1270.0%0.08%
-17.4%
Q3 2021$13,566,000
-17.1%
101,1270.0%0.09%
-17.9%
Q2 2021$16,373,000
+71.3%
101,127
-44.7%
0.11%
+40.0%
Q1 2021$9,558,000
-3.9%
182,9170.0%0.08%
+1.3%
Q4 2020$9,951,000
+521.2%
182,917
+52.4%
0.08%
+276.2%
Q3 2019$1,602,000
-18.1%
120,0000.0%0.02%
-12.5%
Q2 2019$1,956,000
-4.6%
120,0000.0%0.02%
-7.7%
Q1 2019$2,050,000
+25.2%
120,0000.0%0.03%
+4.0%
Q4 2018$1,638,000
-52.3%
120,0000.0%0.02%
-45.7%
Q3 2018$3,434,000
+25.9%
120,000
+20.4%
0.05%
+7.0%
Q2 2018$2,728,000
+61.7%
99,700
+24.6%
0.04%
+48.3%
Q1 2018$1,687,000
+35.1%
80,000
+23.1%
0.03%
+31.8%
Q4 2017$1,249,00065,0000.02%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders